Extracts from oral questions (Commons): Science, Innovation and Technology - May 3

Horizon Europe

Dame Diana Johnson (Kingston upon Hull North) (Lab)

1. What recent progress she has made on negotiating the UK’s association to Horizon Europe.

The Secretary of State for Science, Innovation and Technology (Chloe Smith)

I am thrilled to answer today for the new Department for Science, Innovation and Technology, stepping in while my right hon. Friend the Member for Chippenham (Michelle Donelan) begins her maternity leave. May I also take a moment to wish my colleague, the Minister for Data and Digital Infrastructure, my hon. Friend the Member for Hornchurch and Upminster (Julia Lopez) well? As a Department, we are keen to make maternity leave normal and successful, and it is vital that this House gives support to that.

Outstanding science and research is vital to me, to my right hon. Friend who has started her maternity leave and to the Prime Minister, so we are working hard on the UK’s involvement in Horizon Europe. We hope negotiations will be successful and that it is our preference. However, our participation must be on the basis of a good deal for UK researchers, businesses and taxpayers. If we are not able to associate on the right terms, we will implement our bold, ambitious alternative to Horizon—Pioneer.

Dame Diana Johnson

I welcome the right hon. Lady to her place. Having the University of Hull in my patch, I know very well how important Horizon grants have been to the funding of research and scientific excellence. The Conservative party made a manifesto promise to secure association to Horizon Europe, which is the world’s biggest science funding and collaboration programme. How can universities and scientists plan for the future if that has not been sorted out yet?

Chloe Smith

The right hon. Lady’s question reflects exactly why we are working so hard to achieve that association. However, we need to accommodate the lasting impact of two years of European Union delays to the United Kingdom’s association. Senior scientists, such as Professor Boyle, the chair of the Universities UK relevant network, for example, acknowledge that our approach demonstrates how seriously this issue is being taken by all sides. They also agree that it is entirely appropriate that we have the alternative plan and that the sector can work together with the Government to achieve that.

Dr Neil Hudson (Penrith and The Border) (Con)

I welcome the Secretary of State to her place. 

We have the best scientists, universities and institutions in the world here in the UK. The best science comes from research collaboration. Our UK scientists want to collaborate, and the world wants to collaborate with us. With that in mind, will my right hon. Friend reaffirm the Government’s commitment to rejoining Horizon and similar programmes?

Chloe Smith

As I have already said at this Dispatch Box, I can confirm that association is our preference. However, that must be on the basis of the right deal and a fair set of terms for UK taxpayers, researchers and all others involved. I also gladly confirm that in this Government we see a golden thread that goes from outstanding basic science through research to innovations that change people’s lives, sustain economic growth and create solutions to the challenges of the age.

Commercialisation of Research

Dr Rupa Huq (Ealing Central and Acton) (Lab)

2. What steps she is taking to support the commercialisation of research.

The Minister for Science, Research and Innovation (George Freeman)

Better commercialising our UK research is completely key to our global science superpower and domestic innovation nation missions, and a key component of our science and technology framework and this Department’s work. I am delighted to report that spin-outs from universities have gone up sixfold in the past nine years, to £2.5 billion last year, and in the life sciences sector that has gone up 1000% since we took office. We are creating jobs and opportunities for innovation clusters all around the UK, including in west London.

Dr Huq

We have just heard about uncertainty about Horizon. In addition, there are no more European structural funds and under-investment in R&D. We are hurtling down the global rankings for clinical research trials. The Minister just mentioned life sciences, but last week Novartis, the Swiss pharma giant, pulled out of a major trial for cardiovascular drugs in this country for those very reasons. When will the Government admit that, rather than an example of confidence in the world-beating, post-Brexit life sciences sector that the ex-Health Secretary who went to the jungle claimed at the time it would be, that decision shows what an unmitigated disaster Brexit has been? When will they fix this mess?

George Freeman

Here we go—Labour talking Britain down again. The truth is that I am not at all complacent about the clinical trials numbers. At the Life Sciences Council, in the next few weeks, we will be setting out a very clear plan to reverse the decline since the pandemic in the NHS.

The hon. Lady might have mentioned the major investment coming into west London—her part of the world—including the MedTech SuperConnector, the spin-outs there and SynbiCITE, the synthetic biology hub. She might at least acknowledge the major investment—billions of pounds—from Moderna and BioNTech into this country, laying the foundation for a next phase of science innovation. With the life sciences sector, we are in a global race, but we are still leading in the technologies of tomorrow.

Stephen Metcalfe (South Basildon and East Thurrock) (Con)

Can my hon. Friend comment on the Department’s 10-point science and technology framework, which will help provide the long-term funding needed to turn the start-ups he has mentioned into sustainable, successful, globally leading businesses?

George Freeman

I thank my hon. Friend, who has been a strong champion of that agenda. In the new Department’s science and technology framework we have set out a long-term, 10-year view of the serious reforms that we need to make to procurement, regulation and skills across the whole of Government if we are to drive our science superpower agenda. A fundamental part of that is converting the health of our start-up ecosystem into scale-ups. That is why the Treasury is leading on the re-regulation of pension funds—so that we can unlock some of our pension trillions and put it into supporting our companies to grow here rather than go to NASDAQ.

Commercialisation of Research: North-east England

Mary Kelly Foy (City of Durham) (Lab)
4. What steps she is taking to support the commercialisation of science and technology research in the north-east.

The Minister for Science, Research and Innovation (George Freeman)
Having worked on coalfield regeneration in the north-east, I am delighted to report that it is becoming a science and technology powerhouse economy in the UK. I have been up three times since taking on this role, particularly to see NETPark, the extraordinary north-east technology park, whose third phase of expansion has now been announced. We put £5 million into helping it grow, and world-class companies such as Kromek are now there. We have also put £5 million into the Northern Accelerator in collaboration with six north-east universities, and we have nine Catapult hubs in the north-east. Let us say it loud and clear: the north-east is building the new economy of tomorrow.

Mary Kelly Foy
Led by Durham University, the Northern Accelerator has invested more than £100 million in partner university spin-outs in the past five years, bringing skilled jobs and opportunities to my constituents and across the region, but if the Minister is really serious about levelling up Durham, can he explain why the north-east receives just 4% of Research England’s budget and six times less money than London?

George Freeman
I pay tribute to the hon. Lady’s leadership on this issue, because it is really important. Traditionally, our research funding follows excellence, and that is why, say, Northumbria University has shot up the league tables in the last few years from 42nd to 16th—it is knocking on the door of the Russell Group—and the northern universities are delivering increasingly excellent science. But there is something else. Last year there was £50 billion-worth of private investment in research and development, which is matching the public investment, and as we go to £20 billion of public R&D, a wave of private money will start to come into the north-east. The answer to her question is that this is about building the applied science into the industries of tomorrow, which the north-east is doing.

Mark Pawsey (Rugby) (Con)
Does the Minister agree that the Catapult centres in the north-east, as well as the manufacturing technology centre in my constituency, are the way forward in commercialising some of the great ideas that are coming from the academic world?

George Freeman
Yes, I absolutely agree. That is why we have put £1.9 billion into the Catapult network—our network for deep industrial collaboration with our universities. In the north-east, we have the offshore renewables Catapult in Blyth, the digital Catapult in Sunderland and the satellite applications Catapult in Durham. This is a deep investment in the north-east economy of tomorrow.

Mr Speaker
We now come to the Scottish National party spokesperson.

Carol Monaghan (Glasgow North West) (SNP)
One of the companies based in NETPark is Pragmatic Semiconductor, which is innovating chip production. It has indicated that it would consider moving its operations overseas if the UK fails to produce a semiconductor strategy that funds and supports chip production. We have been asking for this strategy for years now, so can the Minister assure the House not only that the strategy is imminent and will be published very shortly, but that it will properly fund and support companies such as Pragmatic?

George Freeman
Yes. The Under-Secretary of State for Science, Innovation and Technology, my hon. Friend the Member for Sutton and Cheam (Paul Scully), has already met the company concerned, and in a matter of days we will be setting out the semiconductor strategy, which will answer exactly the question that the hon. Lady has raised.